Viewing StudyNCT00007839



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00007839
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2001-01-06

Brief Title: Beta Alethine in Treating Patients With Low-Grade Lymphoma
Sponsor: LifeTime Pharmaceuticals
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
splenic marginal zone lymphoma View
stage I grade 1 follicular lymphoma View
stage I grade 2 follicular lymphoma View
stage I adult diffuse small cleaved cell lymphoma View
stage III grade 1 follicular lymphoma View
stage III grade 2 follicular lymphoma View
stage III adult diffuse small cleaved cell lymphoma View
stage IV grade 1 follicular lymphoma View
stage IV grade 2 follicular lymphoma View
stage IV adult diffuse small cleaved cell lymphoma View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
contiguous stage II grade 1 follicular lymphoma View
contiguous stage II grade 2 follicular lymphoma View
contiguous stage II adult diffuse small cleaved cell lymphoma View
noncontiguous stage II grade 1 follicular lymphoma View
noncontiguous stage II grade 2 follicular lymphoma View
noncontiguous stage II adult diffuse small cleaved cell lymphoma View
noncontiguous stage II small lymphocytic lymphoma View
noncontiguous stage II marginal zone lymphoma View
recurrent marginal zone lymphoma View
recurrent small lymphocytic lymphoma View
stage I marginal zone lymphoma View
stage I small lymphocytic lymphoma View
stage III small lymphocytic lymphoma View
stage III marginal zone lymphoma View
stage IV small lymphocytic lymphoma View
stage IV marginal zone lymphoma View
contiguous stage II marginal zone lymphoma View
contiguous stage II small lymphocytic lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View